Clinical trial
Ph1 Lobeline Interaction Study - 1
NCT00439504 · National Institute on Drug Abuse (NIDA), NIH · Unknown status
Key facts
| NCT number | NCT00439504 |
|---|---|
| Title | Ph1 Lobeline Interaction Study - 1 |
| Official title | Double-Blind, Placebo-Controlled, Cross-Over Assessment of Intravenous Methamphetamine and Sublingual Lobeline Interactions |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Methamphetamine Dependence |
| Intervention type | Drug |
| Interventions | Lobeline |
| Enrollment | 10 |
| First posted | Feb 23, 2007 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: